Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
fx-322 (6 trials)
Deafness (Phase 2)
Hearing Loss (Phase 2)
Hearing Loss, Noise-Induced (Phase 2)
Hearing Loss, Sensorineural (Phase 2)
Hearing Loss, Sudden (Phase 1)
Presbycusis (Phase 1)
Trials (6 total)
Trial APIs (1 total)